Search for Clinical Trial Results

Sponsored By

Parotid Diseases - 25 Studies Found

Status Study
Completed Study Name: Evaluation of Safety and Effectiveness of the FMwand Ferromagnetic Surgical System During Parotidectomy Surgery
Condition: Parotid Diseases
Date: 2014-11-04
Interventions: Procedure: Parotidectomy Surgical Intervention with the FMwand Surgical System
Not yet recruiting Study Name: Gender and Opioid Consumption
Condition: Postoperative; Parotitis
Date: 2016-12-27
Interventions: Drug: postoperative morphine Postoperatively, A loading dose of morphine will be given in incremental do
Recruiting Study Name: SPI-directed Analgesia for Vitreoretinal Surgeries
Condition:
  • Vitreoretinal Surgeries
  • Postoperative Nausea and Vomiting

  • Date: 2016-11-22
    Interventions:
    • Drug: Metamizol in group A pat
Not yet recruiting Study Name: Phase II of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants
Condition: Epidemic Parotitis,Mumps
Date: 2017-04-17
Interventions:
  • Biological: ≥3.0 lgCCID50/mlbut ＜3.5lgCCID50/ml Live Attenuated
Recruiting Study Name: Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella Vaccine
Condition:
  • Encephalitis, Japanese
  • Measles
  • Mumps
  • Biological: CD-JEV Single 0.5

Active, not recruiting Study Name: Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants
Condition: Mumps
Date: 2016-02-23
Interventions:
  • Biological: investigational live attenuated mumps vaccine

Completed Study Name: Post-parotidectomy Facial Paresis: Intraoperative and Postoperative Factors
Condition:
  • Parotid Neoplasms
  • Facial Paralysis

Date: 2015-08-17
Interventions: Behavioral: Facial exercises A series of self-administered facial movements and expressions.
Active, not recruiting Study Name: Feasibility Study of MRI Imaging on Parotid Gland Stimulation
Condition: Parotid Neoplasms
Date: 2014-11-12
Interventions:
  • Device: MRI Participants will

Completed Study Name: Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age
Condition: Measles; Mumps; Rubella
Date: 2014-07-03
Interventions:
  • Biological: GSK Biologicals measles, mumps and rubella vaccine live (GSK 209
Completed Study Name: Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older
Condition:
  • Rubella
  • Mumps
  • Measles

Date: 2014-02-06
Interventions:
  • Biological: Priorix® 1 do
Next >>>